JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Analysis of Interleukin-6 Gene Polymorphisms in Behcet’s Disease Using RFLP and DHPLC
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Analysis of Interleukin-6 Gene Polymorphisms in Behcet’s Disease Using RFLP and DHPLC
Jang, Won-Cheol; Park, Sang-Beom; Nam, Yun-Hyeong; Lee, Jae-Sik;
  PDF(new window)
 Abstract
Behcet`s disease (BD) is a systemic vasculitis characterized by recurrent oral and genital ulcers, and ocular inflammation, and which may involve the joints, skin, central nervous system and gastrointestinal tract. Although the exact pathogenesis for BD is not completely understood, it has been suggested that the disease is triggered in genetically susceptible individuals by environmental factors, such as microbial agents. It is noted that multiple genes, including MHC (major histocompatibility complex) and non-MHC genes, are implicated in the pathogenesis of BD. This study tries to determine whether IL-6 gene polymorphisms are associated with susceptibility to Behcet`s disease in Koreans. Gene polymorphisms were typed by VNTR (variable number of tandem repeat), RFLP (restriction fragment length polymorphism), DHPLC (denaturing high performance liquid chromatography).There were no evidences for genetic association conferred by the IL-6prom polymorphism. However, significant differences in the IL-6vntr genotype and allele frequencies were found between patients with BD and controls. The IL-6vntr*C allele appeared to be an additional susceptibility gene to Korean BD. Further studies in other populations and gene are required to confirm these results.
 Keywords
BD(behcet`s disease);IL-6;DHPLC;RFLP;VNTR
 Language
Korean
 Cited by
1.
변성 고성능 액체 크로마토그래피를 이용한 한우, 젖소 그리고 혼입육의 구분,안영창;조민호;서재원;윤일규;정덕현;이은영;남윤형;박수민;장원철;

대한화학회지, 2009. vol.53. 6, pp.742-748 crossref(new window)
 References
1.
Verity, D. H.; Marr, J. E.; Ohno, S.; Wallace, G. R., Stanford MR. Tissue Antigens, 1999, 5421, 3-20

2.
Bowcock, A. M.; Kidd, J. R.; Lathrop, G. M., Daneshvar L, May LT, Ray A, et al. Genomics, 1988, 3, 8-16 crossref(new window)

3.
Xing, Z.; Gauldie, J.; Cox, G.; Baumann, H.; Jordana, M.; Lei, X. F., et al. J Clin Invest, 1998, 101, 311-20 crossref(new window)

4.
Fishman, D.; Faulds. G.; Jeffery, R.; Mohamed-Ali, V.; Yudkin, J. S.; Humphries, S., et al. J Clin Invest, 1998, 102, 1369-76 crossref(new window)

5.
Ogilvie, E. M.; Fife, M. S.; Thompson, S. D.; Twine, N.; Tsoras, M.; Moroldo, M., et al. Arthritis Rheum, 2003, 48, 3202-6 crossref(new window)

6.
Murray, R. E.; McGuigan, F.; Grant, S. F.; Reid, D. M.; Ralston, S. H., Bone, 1997, 21, 89-92 crossref(new window)

7.
Linker-Israeli, M.; Wallace, D. J.; Prehn, J.; Michael, D.; Honda, M.; Taylor, K. D., et al. Genes Immun, 1999, 1, 45-52 crossref(new window)

8.
Bagli, M.; Papassotiropoulos, A.; Knapp, M.; Jessen, F.; Luise, R. M.; Maier, W., et al. Neurosci Lett, 2000, 283, 109-12 crossref(new window)

9.
Georges, J. L.; Loukaci, V.; Poirier, O.; Evans, A.; Luc, G.; Arveiler, D., et al. J Mol Med, 2001, 79, 300-5 crossref(new window)

10.
Rauramaa, R.; Vaisanen, S. B.; Luong, L. A.; Schmidt-Trucksass, A.; Penttila, I. M.; Bouchard, C., et al. Arterioscler Thromb Vasc Biol, 2000, 20, 2657-62 crossref(new window)

11.
Yamakawa, Y.; Sugita, Y.; Nagatani, T.; Takahashi, S.; Yamakawa, T.; Tanaka, S., et al. J Dermatol Sci, 1996, 11, 189-95 crossref(new window)

12.
Hirohata, S.; Oka, H.; Mizushima, Y., Cell Immunol, 1992, 140, 410-9 crossref(new window)

13.
Chang, H. K.; Cheon, K. S., J Korean Med Sci, 2002, 17, 371-4 crossref(new window)